FDA clears wireless blood analyzer

Abbott Laboratories two weeks ago received clearance from the Food and Drug Administration to begin marketing is i-STAT 1 Wireless blood analyzer, according to company statements.

The handheld unit allows clinicians to perform blood tests at the patient's bedside, and to transmit the results wirelessly to physicians or into electronic medical record systems. For example, emergency department clinicians would be able to test and immediately send off blood samples for an emergency consult, company officials explain. One particular improvement, according to reviewers at MedGadget, is that physicians don't have to synch up to the device in order to receive the findings. The company says the analyzer only requires two to three drops of blood to provide lab-quality results. 

It's the fourth mobile medical device to receive FDA's 501(k) clearance this year. Others include Ascom's Cardiomax monitor/alarm system, Monica Healthcare's AN24 wireless fetal monitor, and Mobisante's MIM mobile ultrasound device.

For more information:
- see the RTT News article
- view the MedGadget article
- view this Abbott press release

Related Articles:
New app helps docs to diagnose blood disorders
Portable, automated device moves blood, urine testing to the exam room

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.